Beatty GL - Search Results

1

Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.

Beatty GL, Li Y, Long KB. Beatty GL, et al. Expert Rev Anticancer Ther. 2017 Feb;17(2):175-186. doi: 10.1080/14737140.2017.1270208. Epub 2016 Dec 14. Expert Rev Anticancer Ther. 2017. PMID: 27927088 Free PMC article. Review.

2

Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.

Beatty GL, Giantonio BJ. Beatty GL, et al. Expert Rev Anticancer Ther. 2008 May;8(5):683-8. doi: 10.1586/14737140.8.5.683. Expert Rev Anticancer Ther. 2008. PMID: 18471041 Review.

3

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.

Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, Torigian DA, O'Dwyer PJ, Vonderheide RH. Beatty GL, et al. Science. 2011 Mar 25;331(6024):1612-6. doi: 10.1126/science.1198443. Science. 2011. PMID: 21436454 Free PMC article. Clinical Trial.

4

CD40 immunotherapy for pancreatic cancer.

Vonderheide RH, Bajor DL, Winograd R, Evans RA, Bayne LJ, Beatty GL. Vonderheide RH, et al. Among authors: beatty gl. Cancer Immunol Immunother. 2013 May;62(5):949-54. doi: 10.1007/s00262-013-1427-5. Epub 2013 Apr 16. Cancer Immunol Immunother. 2013. PMID: 23589109 Free PMC article. Review.

5

A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.

Beatty GL, Torigian DA, Chiorean EG, Saboury B, Brothers A, Alavi A, Troxel AB, Sun W, Teitelbaum UR, Vonderheide RH, O'Dwyer PJ. Beatty GL, et al. Clin Cancer Res. 2013 Nov 15;19(22):6286-95. doi: 10.1158/1078-0432.CCR-13-1320. Epub 2013 Aug 27. Clin Cancer Res. 2013. PMID: 23983255 Free PMC article. Clinical Trial.

6

Harnessing the antitumor potential of macrophages for cancer immunotherapy.

Long KB, Beatty GL. Long KB, et al. Among authors: beatty gl. Oncoimmunology. 2013 Dec 1;2(12):e26860. doi: 10.4161/onci.26860. Epub 2013 Nov 4. Oncoimmunology. 2013. PMID: 24498559 Free PMC article. Review.

7

Immune escape mechanisms as a guide for cancer immunotherapy.

Beatty GL, Gladney WL. Beatty GL, et al. Clin Cancer Res. 2015 Feb 15;21(4):687-92. doi: 10.1158/1078-0432.CCR-14-1860. Epub 2014 Dec 12. Clin Cancer Res. 2015. PMID: 25501578 Free PMC article. Review.

8

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.

Beatty GL, Winograd R, Evans RA, Long KB, Luque SL, Lee JW, Clendenin C, Gladney WL, Knoblock DM, Guirnalda PD, Vonderheide RH. Beatty GL, et al. Gastroenterology. 2015 Jul;149(1):201-10. doi: 10.1053/j.gastro.2015.04.010. Epub 2015 Apr 14. Gastroenterology. 2015. PMID: 25888329 Free PMC article.

9

IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma.

Long KB, Gladney WL, Tooker GM, Graham K, Fraietta JA, Beatty GL. Long KB, et al. Among authors: beatty gl. Cancer Discov. 2016 Apr;6(4):400-413. doi: 10.1158/2159-8290.CD-15-1032. Epub 2016 Feb 19. Cancer Discov. 2016. PMID: 26896096 Free PMC article.

10

Overcoming Therapeutic Resistance by Targeting Cancer Inflammation.

Beatty GL. Beatty GL. Am Soc Clin Oncol Educ Book. 2016;35:e168-73. doi: 10.1200/EDBK_158948. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249720 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page